Related by context. All words. (Click for frequent words.) 69 somatic mutations 68 pituitary adenomas 68 genetic loci 67 pathogenic mechanisms 67 chromosomal rearrangement 67 histone modifications 67 molecular subtypes 67 genomic alterations 67 molecular abnormalities 66 pre malignant lesions 66 etiologic 65 promoter hypermethylation 65 chromosome aberrations 65 genetic determinants 65 virulence genes 65 underlying pathophysiology 65 prognostic markers 65 EGF receptors 64 miRNA expression 64 SMAD4 64 epigenetic mechanisms 64 DNA methylation patterns 64 precursor lesions 64 cellular pathways 64 epigenetic modification 64 causal variants 64 splice junctions 64 modifier genes 64 MAPK pathway 64 Histologically 64 epithelial tumors 64 susceptibility loci 64 oncogenic mutations 64 sCJD 63 epigenetic alterations 63 underlying molecular mechanisms 63 signaling cascades 63 epigenetic markers 63 hamartomas 63 BRAF gene 63 etiologic factors 63 biologic pathways 63 missense mutations 63 molecular biomarkers 63 extramedullary 63 cervical lymph nodes 63 familial clustering 63 genetic polymorphisms 63 IDH mutations 63 molecular determinants 63 microRNA expression 63 mucinous 63 MECP2 gene 63 anti angiogenic drugs 63 genetic heterogeneity 62 premalignant lesions 62 breast carcinomas 62 epigenetic changes 62 gene rearrangements 62 Genetic variants 62 Chronic pancreatitis 62 clinicopathologic 62 PI3K AKT 62 gene fusions 62 glial tumors 62 epigenetic modifications 62 neoplastic 62 HLA DRB1 62 oncogenesis 62 FGFs 62 carcinoids 62 chromosomal instability 62 FGFR2 62 FOXM1 62 N. gonorrhoeae 62 fungal genomes 62 enterotypes 62 posttranslational modifications 62 renal cysts 62 herpesviruses 62 p# mutations 62 MGUS 62 druggable targets 62 distinct subtypes 62 chromosomal aberrations 62 seminomas 62 tumor subtypes 62 K ras mutations 61 mammary cells 61 prognostic marker 61 causative mutations 61 myelomas 61 PCNSL 61 pathogenic mutations 61 metabolomic profiles 61 mtDNA mutations 61 aneuploidies 61 hepatic stellate cells 61 TP# gene 61 telomere lengths 61 monogenic 61 histological subtypes 61 noncoding RNAs 61 mammary duct 61 spontaneous mutations 61 calculi 61 TTR gene 61 nucleoli 61 adenomatous polyp 61 ependymomas 61 chromosomal regions 61 TGF beta signaling 61 STAT3 signaling 61 causative genes 61 histologic subtypes 61 mRNA molecules 61 microbiomes 61 gene duplications 61 germline mutations 61 microRNA molecules 61 germline mutation 61 MSH2 61 de novo mutations 61 carcinoid 61 aerodigestive tract 61 biologic pathway 61 chromosomal alterations 61 Epstein Barr virus EBV 61 Genetic mutations 61 skeletal metastases 61 Brugada syndrome 61 intracellular bacteria 61 epigenetic regulation 61 hypermethylated 61 renal fibrosis 61 serum biomarkers 61 myelofibrosis polycythemia vera 61 endophenotypes 61 aberrant activation 61 motor neuron degeneration 61 susceptibility gene 61 pilocytic astrocytomas 61 intracellular signal transduction 61 breast cancer subtypes 61 genetic locus 61 VHL gene 61 lymphocytic 60 histologies 60 cell signaling pathways 60 oncogenic transformation 60 pathophysiologic 60 clefting 60 genetic susceptibilities 60 ALK mutations 60 myeloproliferative diseases 60 biochemical abnormalities 60 PrPSc 60 mesotheliomas 60 microRNA biomarkers 60 miRNA expression patterns 60 gene amplification 60 metaplasia 60 circadian genes 60 RNA sequences 60 epithelial cancers 60 trophoblasts 60 prostate cancer CaP 60 chromosome rearrangements 60 breast cancer metastasis 60 transgene expression 60 KIT mutations 60 PTEN mutations 60 aberrant methylation 60 malignant phenotype 60 kinase inhibition 60 antibody mediated 60 genomic rearrangements 60 C. neoformans 60 chromosome translocations 60 genomic variants 60 conserved sequences 60 oligodendrogliomas 60 prognostic indicators 60 RRM1 60 gastric adenocarcinoma 60 subclinical disease 60 synovial cells 60 microsatellite instability 60 follicular dendritic cells 60 neuroblastoma tumors 60 stem cells CSCs 60 Wnt signaling pathway 60 epithelial tissues 60 primate genomes 60 GIST tumors 60 uPAR 60 UCRs 60 immunofluorescent 60 hypermethylation 60 Genetic profiling 60 BCR ABL mutations 60 splice variants 60 APOE genotype 60 beta1 integrin 60 EBV infection 60 microdeletions 60 gene expression patterns 60 methylation markers 60 genomic instability 60 hereditary predisposition 60 oncoproteins 60 Genetic predisposition 60 segmental duplications 60 PCA3 gene 60 mutations 60 cyclin E 60 echogenic foci 60 nucleotide substitutions 60 TCF#L# gene 60 MMP# 60 mitochondrial toxicity 60 benign moles 60 androgen receptor AR 60 metastatic tumors 60 BRAF mutation 60 GISTs 60 node metastases 60 renal cell carcinomas 60 mitochondrial disorders 60 epithelial cell 60 subtypes 60 neuropsychiatric diseases 60 osteogenic differentiation 60 PTPN# 60 vimentin 60 aetiology 60 KIAA# 60 DSBs 60 primary cilia 60 phenotypic variation 59 virulence determinants 59 genomic variation 59 prion infection 59 BRAF V#E 59 vacuolar 59 LRP5 59 leiomyoma 59 pulmonary metastases 59 phenotypic differences 59 HER2 overexpression 59 brain lesions 59 neuroendocrine cancers 59 prognostically 59 protein isoforms 59 protein tyrosine phosphatase 59 bronchial epithelial cells 59 KRAS oncogene 59 tumor metastases 59 Metastatic colorectal cancer 59 genetic alterations 59 phenotypic variability 59 carotid plaques 59 granulosa cell 59 colorectal adenocarcinoma 59 cytologically 59 familial pancreatic cancer 59 infectious prion proteins 59 protein tyrosine phosphatases 59 proto oncogene 59 plexiform 59 vertebrate embryos 59 chromosomal translocations 59 DNA rearrangements 59 humoral immune response 59 clinicopathological 59 Kaplan Meier curve 59 myopathies 59 paralogs 59 N Myc 59 immunohistochemical staining 59 leiomyomas 59 metastatic neuroendocrine tumors 59 tumor biopsies 59 STK# [002] 59 colorectal carcinogenesis 59 repolarization 59 methylation patterns 59 multigene 59 neuropathologic 59 pharmacologic intervention 59 DNA demethylation 59 PARP inhibition 59 metastatic lesions 59 viral genomes 59 costimulatory 59 podocyte 59 lung adenocarcinoma 59 nasopharyngeal carcinoma NPC 59 HLA molecules 59 NKG2D 59 amyloidogenic 59 ERBB2 59 Activating mutations 59 cAMP signaling 59 Genetic mutation 59 gastrointestinal stromal tumors GISTs 59 HBV replication 59 GPC5 59 telomere dysfunction 59 epigenetic reprogramming 59 prognostic biomarkers 59 STAT4 59 etiologic agent 59 previously uncharacterized 59 Genetic variations 59 HG PIN 59 renal carcinoma 59 aneuploid cells 59 malignant lymphomas 59 fascin 59 epistasis 59 susceptibility genes 59 paragangliomas 59 clonal expansion 59 phenotypic expression 59 H#Y 59 malignant transformation 59 biomarker identification 59 normal prion protein 59 inherited mutations 59 CYT# potent vascular disrupting 59 BRCA1 BRCA2 59 tumor suppressor protein 59 ERK signaling 59 SSc 59 HbF 59 tau aggregates 59 #S rRNA 59 mitochondrial mutations 59 quasispecies 59 Stat5 59 EML4 ALK 59 serous ovarian cancer 59 WT1 59 Hedgehog signaling 59 clade B 59 EGFR pathway 59 anemias 59 mRNA transcripts 59 noncancerous cells 58 transgenic mouse model 58 astrocytomas 58 #q# deletion 58 GLUT1 58 globin gene 58 gene polymorphisms 58 cisplatin resistant 58 mesenchymal cell 58 haematopoietic 58 microvessels 58 N glycan 58 protein coding RNAs 58 osteochondromas 58 neoplastic lesions 58 gene locus 58 molecular signaling pathways 58 S. maltophilia 58 histological subtype 58 ADAMTS# 58 desmosomes 58 indels 58 nongenetic 58 NSCLC tumors 58 BRAF protein 58 Sjögren syndrome 58 basal cells 58 chromosomal mutations 58 melanocytic 58 explanatory variables 58 vitamin D receptors 58 tumorigenicity 58 squamous cell lung cancer 58 chromosome #p#.# 58 chlamydial infection 58 etiologies 58 micro RNAs 58 murine models 58 nodal metastasis 58 IntroductionThe 58 CYP#D# gene 58 Wnt proteins 58 chemosensitivity 58 prognostic indicator 58 provirus 58 ZNF# 58 childhood leukemias 58 JAK mutations 58 BRCA2 gene mutations 58 subcellular compartments 58 previously undescribed 58 Telomere length 58 uncharacterized genes 58 Accurately identifying 58 non coding RNA 58 prognostic significance 58 BCL6 gene 58 FGFR1 58 putative biomarkers 58 fluoroquinolone resistance 58 miRNA molecules 58 pleiotropic 58 GBM tumors 58 hepatocellular carcinomas 58 abzymes 58 luminal cells 58 amyloid plaque formation 58 CNTNAP2 58 perfusion abnormalities 58 MMP inhibitors 58 Telomere shortening 58 autoinflammatory diseases 58 histone modification 58 Epstein Barr Virus EBV 58 biochemical marker 58 myofibroblasts 58 TP# mutation 58 cDNA libraries 58 DCIS lesions 58 sporadic ALS 58 molecular underpinnings 58 causative agents 58 multigenic 58 coding exons 58 untranslated regions 58 supratentorial 58 Leukemias 58 HSV1 58 neuronal circuitry 58 mutant SOD1 58 meningiomas 58 atrioventricular 58 lobular carcinomas 58 ADPKD 58 activating mutations 58 pathophysiologic mechanisms 58 drug metabolizing enzymes 58 generalized vitiligo 58 miRs 58 bilaterians 58 chromatin structure 58 replicase 58 familial aggregation 58 TMPRSS2 ERG fusion 58 gastric cardia 58 deCODE BreastCancer TM 58 immunocompetent 58 FGFR3 58 intercellular signaling 58 mosaicism 58 lymphatic tissue 58 prostate carcinogenesis 58 diagnostic biomarker 58 immunostaining 58 osteosarcomas 58 serologic tests 58 MT1 MMP 58 ALK gene 58 neuro endocrine 58 differential gene expression 58 plexiform neurofibromas 58 percutaneous biopsy 58 Candida infection 58 p# activation 58 Helicobacter 58 biochemical signaling pathway 58 mitochondrial gene 58 atherothrombotic 58 genetic variants associated 58 C. pneumoniae 58 esophagogastric junction 58 TGF beta pathway 58 lymphoid tumors 58 infecting organism 58 leukemic stem cells 58 proliferative disorders 58 LRRK2 gene 58 multiplex ligation dependent 58 susceptibility alleles 58 differentially expressed genes 58 deCODE BreastCancer 58 gene loci 58 multidrug resistance 58 myeloproliferative 58 Prognostic factors 58 presymptomatic 58 C1q 58 sequence homology 58 medulloblastomas 58 gastric carcinoma 58 genetic mutations 58 Hurthle cell 58 Basal cell 58 MAP#K# 58 PPARg 58 HCV replication 58 Oxidative damage 58 nanobacteria 58 neuroanatomical 58 lymphoid cells 57 ribosomal DNA 57 familial ALS 57 gastric carcinomas 57 immunological responses 57 epigenetic inheritance 57 incidentalomas 57 intracellular pathways 57 mycobacterial 57 neural crest 57 tumor histology 57 oncogene addiction 57 epithelial barrier 57 astrocytic 57 hyperplastic 57 testicular germ cell 57 isotypes 57 neoplastic transformation 57 gynecologic malignancy 57 Alu elements 57 p# alpha [002] 57 mitochondrial DNA mtDNA 57 phylogenetic analyzes 57 pathophysiological 57 orthologous genes 57 LIS1 57 immunohistochemical analysis 57 tyrosine phosphorylation 57 Prion diseases 57 morphologic 57 histone acetylation 57 immunoregulation 57 Drosophila genome 57 nonmelanoma skin cancers 57 leukaemic stem cells 57 Li Fraumeni 57 ARF1 57 CDH1 57 androgen receptor signaling 57 adenomatous polyps 57 epigenetically 57 osteoid 57 tissue fibrosis 57 microcalcifications 57 sarcosine 57 genome rearrangements 57 neurocognitive impairment 57 OGG1 57 metastatic lymph nodes 57 evolutionarily conserved 57 Genetic variation 57 histologic subtype 57 Candida species 57 endostatin 57 prostate carcinoma 57 Multiple logistic regression 57 breast cancer susceptibility genes 57 angiographically 57 arterial calcification 57 hematopoietic malignancies 57 lymphangiogenesis 57 mutated protein 57 genomewide 57 MIF protein 57 nucleotide sequences 57 IGF IR 57 quantitative trait loci 57 gliosis 57 epithelia 57 pancreatic adenocarcinoma 57 cell adhesion molecules 57 mammographically 57 radiochemotherapy 57 malignant prostate 57 genes BRCA1 57 colocalization 57 outer membrane proteins 57 physiologic mechanisms 57 micronuclei 57 cis regulatory 57 coding sequences 57 CD# expression [001] 57 SOD1 gene 57 epithelial markers 57 small molecule activators 57 precancerous stem cells 57 dentinal hypersensitivity 57 nucleotide sequence 57 Nanobacteria 57 genes encode proteins 57 histopathologic examination 57 demyelinating 57 aT cell 57 metabolizing enzymes 57 mechanistic pathways 57 mutated genes 57 #S rRNA gene 57 mitochondrial proteins 57 lymphoid tissues 57 Immunohistochemical analysis 57 JAK STAT 57 K ras gene 57 MLH1 57 MYH9 gene 57 activating mutation 57 da mage 57 NFTs 57 somatic mutation 57 anti apoptotic proteins 57 innate immune responses 57 hamartoma 57 ribonucleic acids 57 malignancies 57 pancreatic endocrine 57 COL#A# 57 mutant genes 57 nonmelanoma 57 TGF b 57 neurite outgrowth 57 DLX5 57 shRNAs 57 PIK3CA 57 Prostatitis 57 Wnts 57 ABL1 57 atypical hyperplasia 57 FLT3 57 cell nuclei 57 Squamous 57 etiological factors 57 Plasmodium vivax 57 nucleic acid sequence 57 phenotypes 57 pulmonary metastasis 57 MYCN amplification 57 MAP kinase pathway 57 MEF2D 57 dermatophytes 57 pathogenetic 57 cellular prion protein 57 anatomical abnormalities 57 atrial tachyarrhythmias 57 oxidized lipids 57 cardiac biomarkers 57 missense mutation 57 microarray datasets 57 etiological agent 57 P cadherin 57 Cathepsin B 57 monocytic 57 CD# expression [002] 57 homologies 57 EGFR protein 57 gene mutations 57 oncoprotein 57 commonly mutated genes 57 monoclonal gammopathy 57 Prox1 57 chronicity 57 idiopathic pulmonary 57 mutant proteins 57 allogeneic HSCT 57 p# mutation 57 synaptogenesis 57 amino acid substitutions 57 eukaryotic cells 57 gene deletions 57 BCR ABL protein 57 CMV infections 57 intestinal epithelium 57 Brain metastases 57 Thyroid nodules 57 tRNA synthetases 57 environmental toxicants 57 retroviral vectors 57 Previous epidemiological studies 57 microdeletion 57 upregulating 57 miRNA genes 57 TLE3 57 neural progenitor cells 57 protein misfolding 57 transcriptional repressor 57 metazoan 57 hematologic disorders 57 ataxias 57 prion strains 57 histone code 57 salivary proteins 57 survivin expression 57 TACI mutations 57 Hashimoto thyroiditis 57 neoplasm 57 chemoresistance 57 promoter methylation 57 malignant nodules 57 clinico pathological 57 cardiac fibrosis 57 EGFR inhibitors 57 SCN5A 57 genomically 57 demyelinating diseases 57 L1 retrotransposons 57 nucleases 57 OnDose TM 57 proteomic analysis 57 Treg cell 57 NF kB pathway 57 miR #a [002] 57 malignant lesions 57 Dpp 56 ectopic expression 56 diagnostic biomarkers 56 Protein misfolding 56 biomarkers 56 plasma kallikrein 56 FGF signaling 56 CRISPR Cas 56 Th2 immune 56 apoptotic pathway 56 acinar 56 imatinib resistance 56 mutated EGFR 56 sarcomatoid 56 bone marrow mesenchymal stem 56 sputum specimens 56 E. faecalis 56 microvascular disease 56 histone deacetylases 56 PTEN gene 56 ALK inhibitors 56 sporadic Creutzfeldt Jakob 56 multinucleated 56 KRAS mutant 56 antiproliferative effects 56 cellularity 56 molecularly targeted therapies 56 genetic recombination 56 validating biomarkers 56 trastuzumab resistant 56 neutralizing antibody responses 56 neuronal dysfunction 56 synovial tissue 56 attentional blink 56 systemic amyloidosis 56 mammary stem cells 56 biologies 56 cathepsins 56 mutated K ras 56 Colon polyps 56 Venous thromboembolism 56 cutaneous lesions 56 autoreactive T cells 56 liver metastasis 56 granzyme B 56 viral isolates 56 kinase gene 56 kidney urologic 56 NPM1 gene 56 Lymph node 56 immunosuppressive regimens 56 antiangiogenic agents 56 lung carcinomas 56 Comparative genomics 56 mutant enzymes 56 Ras oncogene 56 molecular pathways 56 cardiac allograft vasculopathy 56 genotype phenotype 56 basal cell nevus syndrome 56 sensory receptors 56 cytoskeletal structure 56 effector molecules 56 metalloprotease 56 Circulating tumor cells 56 connective tissue diseases 56 microvessel 56 mesenteric 56 microcephalin 56 beta globin gene 56 insoluble plaques 56 myeloproliferative neoplasms 56 Tr DNA 56 ccRCC 56 EBNA1 56 ERK pathway 56 TGFBR1 * 6A 56 amyloid formation 56 Sezary syndrome 56 FUS protein 56 Thyroid disorders 56 telomere DNA 56 protein p# 56 breast endometrial 56 etiological 56 HNSCC 56 TMEM density 56 genes differentially expressed 56 HDAC inhibition 56 neuro degenerative disorders 56 kinase domain 56 ncRNAs 56 HLA DR 56 differentially expressed proteins 56 GPx 56 electrophysiologic 56 Glioblastoma multiforme 56 M. pneumoniae 56 Nanobodies ® 56 endometrial cancers 56 neurobiological mechanisms 56 atherosclerotic disease 56 clonogenic 56 cystic lesions 56 ciliopathies 56 serum antibodies 56 prophylactic cranial irradiation 56 NF1 gene 56 monozygotic twins 56 epigenomic 56 EGFR mutation status 56 Gliomas 56 neurobiological underpinnings 56 NF kB signaling 56 spontaneous regression 56 NKX#.# 56 neurofibroma 56 GSK3B 56 EGFR tyrosine kinase inhibitors 56 effector protein 56 Wnt pathway 56 Metastases 56 Recurrences 56 cytokine receptors 56 splice variant 56 T#M 56 neuroligins 56 JAK STAT signaling 56 ncRNA 56 Sporadic CJD 56 lymphoid 56 SNP rs# [002] 56 IgA deficiency 56 Leydig cell 56 Smad3 56 colorectal adenoma 56 genomic deletions 56 muscular dystrophies 56 human leukocyte antigens 56 causal pathways 56 latent tuberculosis TB 56 fibrotic disease 56 MLL2 56 peptide antigens 56 cofactors 56 abnormal glucose metabolism 56 BARD1 56 nonhereditary 56 B7 H4 56 pathophysiological mechanisms 56 opportunistic pathogens 56 integrin activation 56 ABCB1 56 HPVs 56 proliferative diseases 56 progranulin gene 56 glycolipids 56 genetic abnormalities 56 intracellular proteins 56 IGFBP2 56 HER2 neu 56 Htt 56 nucleolar 56 CpG island 56 chronic inflammations 56 lymphoblastoid cell lines 56 micrometastases 56 PHLPP 56 RNA ribonucleic acid 56 p tau 56 CDK8 56 GABAergic interneurons 56 genomewide association studies 56 genomic rearrangement 56 antiangiogenic therapy 56 Bcr Abl mutations 56 MYH9 56 oncogenic 56 Notch signaling 56 commensal bacteria 56 clonally 56 Fas ligand 56 tonsillar 56 CDK4 56 androgen signaling 56 autoantigens 56 HOX genes 56 cellular organelles 56 chromosomal anomalies 56 chromatin proteins 56 chromosomal anomaly 56 SPINK1 56 nomograms 56 mutant BRAF 56 amino acid sequences 56 epithelioid 56 messenger RNAs mRNAs 56 microRNA genes 56 immunohistochemical 56 neurologic complications 56 prostate cancer PCa 56 MC4R gene 56 Cre recombinase 56 segmental duplication 56 Phylogenetic analyzes 56 S. aureus colonization 56 subcortical regions 56 proteomes 56 phenotypic traits 56 IKZF1 56 gene expression profiles 56 papillomas 56 thyroid nodules 56 virotherapy 56 highly vascularized 56 endocytic 56 RNA polymerases 56 JAK2 enzyme 56 transcriptional profiles 56 thymidylate synthase TS 56 colorectal gastric 56 antisense oligonucleotides 56 vascular dysfunction 56 hematopoetic stem cells 56 teratoma 56 ribonucleic acid RNA 56 neoplasias 56 oligomerization 56 sonographic findings 56 nonvaccine 56 suppressor gene 56 radiographic findings 56 NP CRNs 56 mitochondrial defects 56 transcriptional regulation 56 genetic biomarkers 56 exosome 56 Mathematical modeling 56 astrocyte cells 56 effector function 56 metabolomic profiling 56 spongiform encephalopathies 56 oncogenic signaling 56 neoplastic cells 56 CaM kinase II 56 short hairpin RNAs 56 neuroinflammation 56 sonographic appearance 56 mucosal immunity 56 PCa 56 intra abdominal abscess 56 fulminant hepatic failure 56 intercellular communication 56 ascertainment bias 56 viral antigens 56 telomerase inhibition 56 malarial parasites 56 ovarian pancreatic 56 BCL#A 56 lymph node enlargement 56 renal tumors 56 chromosomal deletions 56 mesothelin 56 LVNC 56 Chlamydia pneumoniae 56 cDNAs 56 Sertoli cell 56 transgenic mouse models 56 biochemical mechanisms 56 oncogenes 56 adeno associated viruses 56 chromosomal DNA 56 transcriptional machinery 56 cardioembolic stroke 56 breast cancer gene mutation 56 HOTAIR 56 melanocytic nevi 56 lung epithelium 56 TNFa 56 carbohydrate antigens 56 β1